PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.02 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $35.1 million versus the consensus estimate of $33.44 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.